This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group	Dosage
Adult	Disease: Prolactinoma Before or After Meal: After Meal Single Maximum Dose: 0.25 mg Dosage Form: Tablet Dosage Route: Oral Frequency: 2 Weekly Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor
Geriatric	Disease: Prolactinoma Before or After Meal: After Meal Single Maximum Dose: 0.25 mg Dosage Form: Tablet Dosage Route: Oral Frequency: 2 Weekly Course Duration: As directed by the doctor Special Instructions: As prescribed by the doctor

Cabergoline Related Warnings

Is the use of Cabergoline safe for pregnant women?

Cabergoline has little to no side effects in pregnant women.

Mild
Is the use of Cabergoline safe during breastfeeding?

Cabergoline should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.

Severe
What is the effect of Cabergoline on the Kidneys?

Cabergoline can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.

Moderate
What is the effect of Cabergoline on the Liver?

You may experience side effects on your liver after taking Cabergoline. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.

Moderate
What is the effect of Cabergoline on the Heart?

The heart can be affected by Cabergoline. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.

Moderate

Severe Interaction of Cabergoline with Other Drugs

Cabergoline should not be taken with following medicines due to severe side effects it may cause to patients -

Severe

Propranolol

Atenolol

Haloperidol

Moderate

Citalopram

Paroxetine

Mild

Amlodipine

Cabergoline Contraindications

If you are suffering from any of the following diseases, you should not take Cabergoline unless your doctor advises you to do so -

High Blood Pressure
Heart Disease
Depression
Liver Disease

Frequently asked Questions about Cabergoline

Is this Cabergoline habit forming or addictive?

No, you will not get addicted to Cabergoline.

No
Is it safe to drive or operate heavy machinery when consuming?

No, you should do not do anything that requires concentration and attention as the Cabergoline can make you feel drowsy.

Dangerous
Is it safe?

Yes, but take Cabergoline only as per medical advice.

Safe, but take only on Doctor's advise
Is it able to treat mental disorders?

Cabergoline is unable to treat or cure mental disorders.

No

Cabergoline Interactions with Food and Alcohol

Interaction between Food and Cabergoline

Due to a lack of research, nothing can be said about the consequences of taking Cabergoline together with food.

Unknown
Interaction between Alcohol and Cabergoline

Drinking alcohol while taking Cabergoline may lead to slight side effects. If you experience any side effects, contact your doctor.

Mild

See all substitutes for Cabergoline

Caberlin 0.5 Mg Tablet - ₹397.1
Caberlin 0.25 Mg Tablet - ₹178.6
Cabgolin 0.5 Mg Tablet - ₹436.05
Cabgolin 0.25 Mg Tablet - ₹195.7
Cabgon 0.25 Tablet - ₹45.0
Cabliz 0.5 Tablet - ₹202.0
Cabliz 0.25 Tablet - ₹87.0
Colette 0.5 Mg Tablet - ₹90.0
Lactocab Tablet - ₹160.0
TTCab Tablet - ₹354.0
Cabercet Tablet - ₹132.0
Caberlact 0.25 Tablet - ₹66.0
Caberlact 0.5 Tablet - ₹140.0
Cabgon 0.5 MG - ₹124.0
Camforte 0.5 Tablet - ₹193.2
Camforte 0.25 Tablet - ₹87.8
Colette 0.25 Mg Tablet - ₹90.0
Golin 0.25 Mg Tablet - ₹46.74
Golin 0.5 Mg Tablet - ₹104.81
Zuricab Tablet - ₹115.23

This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
3 Years of Experience

References

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)